IRB-HSR Home Institutional Review Board for Health Sciences Research
For: 
Researchers IRB Members Research Subjects IRB STaff


 

 

 

 

 

 

+ Calendars & Deadlines
+ Office Information
+ Directions & Hours
+ Staff Directory
+ Frequently Asked Questions
+ IRB-HSR Membership Lists
+ FWA Information
+ Organizational Charts
+ Research Concerns
+ Standard Operating Procedures
 
+ Getting Started
+ Protocol Review Process
+ Managing Protocol After Initial Approval
+ Special Issues
   
+ Protocol Builder and IRB On-Line: On Grounds or UVa VPN access only
+ Forms
+ CITI Training
+ Education
+ Regulations/Guidelines
+ Ethical Principles
+ Search IRB-HSR Protocols
+ Glossary/Acronyms
+ Useful Websites
   
+ Go to full list >>

 

IRB-HSR > Special Issues > Genetic Research

 

 

 

 

 

 

Genetic Research

Federal guidelines strongly advise IRBs to consider specific issues when reviewing clinical genetic research and to alert investigators engaged in such research to address these issues in their application for IRB approval. Unlike the risks presented by biomedical research, the primary risks of genetic research are risks of social and psychological harm rather than risks of physical injury. Genetic studies that generate information about subjects' personal health risks can provoke anxiety and confusion, damage familial relationships, and compromise subjects' insurability and employment opportunities. Although these genetic studies may be limited to a collection of family histories or blood draws, the IRB does not necessarily consider them to be minimal risk.

What qualifies as genetic research?

Genetic research does not mean only research that involves looking for mutations in DNA. Research that involves looking at the differences between proteins in individuals with or without a certain disease can also qualify as genetic research. Records research involving information that was derived from a previous genetic test can also qualify as genetic research. See definitions below.

  • Genetic research: Research using human DNA samples, genetic testing or genetic information.
  • Genetic information: Information about an individual or the individual's blood relatives obtained from a genetic test.
  • Genetic test: A test for determining the presence or absence of genetic characteristics in a human individual or the individual's blood relatives, including tests of nucleic acids, such as DNA, RNA, and mitochondrial DNA, chromosomes or proteins in order to diagnose or determine a genetic characteristic.
  • Genetic characteristic: A gene, chromosome or alteration thereof that may be tested to determine the existence of or risk for acquiring a disease, disorder, trait, propensity or syndrome, or to identify an individual or a blood relative. "Genetic characteristic" does not include family history or a genetically transmitted characteristic whose existence or identity is determined by means other than through a genetic test.

Disclosure of research results to subjects

Disclosure of genetic research findings to a research subject or the subject's physician through use of personal identifiers should not occur unless:

  1. The research findings are scientifically valid and confirmed (done in a CLIA approved lab);
  2. The findings have significant implications for the subject's or the public's health; and
  3. A course of action to ameliorate or treat the subject's or the public's health concerns is readily available.

. In the event these conditions are met, the results may only be released to the subject or any other party with the subject's permission, and appropriate medical advice and referral must be provided.

IRB approval is required before disclosure of research results can occur.

Recontact of a research subject or a patient from whom samples or information was obtained originally for clinical purposes should not occur unless the subject was informed during the initial treatment or research consent and authorization process, that recontact may occur under specified circumstances. Reasons for recontacting research subjects can include recontact for release of clinically relevant research results. If this is desired, precautions must be taken both to minimize the potential harm to subjects of receiving bad news and to guard against the unintended release of the information. The precautions needed in conveying genetic testing results depend on the age at onset of the disorder, the burden of illness, and the availability of treatment or prevention. The communication of genetic information carries with it the responsibility to interpret the results and provide care for the individual; and, thus, it is ideally done in the setting of a clinical rather than research relationship with the subject. Because of the complexity of the results of most genetic tests, subjects cannot be required to inform relatives of the results of the research

*Taken from UVa IRB-HSR Research Guidance